Weary of endless chatter about Martin Shkreli, Turing Pharma, and pharmaceutical drug pricing? Then enjoy a fresh installment of the Biotech Reading List instead!
Reality Check: Cancer Experts Discuss Hurdles Facing CAR-T Therapy
Ben Fidler (Xconomy) $JUNO $KITE
The Fake Drug Industry Is Exploding, and We Can’t Do Anything About It
Alexandra Ossola (Newsweek)
These Venture Capitalists Bet on a Miracle Fat Pill and Lost
Caroline Chen (Bloomberg Business)
The Promoting Life-Saving New Therapies for Neonates Act of 2015: A New Twist on Transferable Vouchers
Kurt Karst (FDA Law Blog)
The Junior Analyst's Guide To Biotech Investment Banking &
Five Reasons Why Your Biotech Comparative Value Theory Is Wrong
two more instant classics from David Sable (Forbes)
Ben Fidler (Xconomy) $JUNO $KITE
The Fake Drug Industry Is Exploding, and We Can’t Do Anything About It
Alexandra Ossola (Newsweek)
These Venture Capitalists Bet on a Miracle Fat Pill and Lost
Caroline Chen (Bloomberg Business)
The Promoting Life-Saving New Therapies for Neonates Act of 2015: A New Twist on Transferable Vouchers
Kurt Karst (FDA Law Blog)
The Junior Analyst's Guide To Biotech Investment Banking &
Five Reasons Why Your Biotech Comparative Value Theory Is Wrong
two more instant classics from David Sable (Forbes)
RSS Feed
